ALB and bronchiectasis: Additionally, we found the compound-ALB binding corresponds to “response to drug” in the GO functional category biological process, which suggeststhe pharmacokinetics of the components in BMGLF may be linked to the efficacy of BMGLF against bronchiectasis.